J. Nam

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

Josef S Smolen, Robert Landewé, Ferdinand C. Breedveld et al. · Annals of the Rheumatic Diseases · 2013 · 1.8K citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

Josef S Smolen, R. B. M. Landewé, F. C. Breedveld et al. · Annals of the Rheumatic Diseases · 2010 · 410 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +14

Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study

Chadi Rakieh, J. Nam, Laura Hunt et al. · Annals of the Rheumatic Diseases · 2014 · 239 citations

Medicine, Immunology, Internal Medicine +15

Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study)

J. Nam, Édith Villeneuve, E. Hensor et al. · Annals of the Rheumatic Diseases · 2013 · 164 citations

Medicine, Clinical Sciences, Pharmacotherapy +15

Ultrasound findings predict progression to inflammatory arthritis in anti-CCP antibody-positive patients without clinical synovitis

J. Nam, E. Hensor, Laura Hunt et al. · Annals of the Rheumatic Diseases · 2016 · 130 citations

Medicine, Immunology, Orthopaedic Surgery +17